Journal of Hematology & Oncology

official impact factor 2.93

Open Access

Ovarian cancer immunotherapy: opportunities, progresses and challenges

Bei Liu*, John Nash, Carolyn Runowicz, Helen Swede, Richard Stevens and Zihai Li

Journal of Hematology & Oncology 2010, 3:7 doi:10.1186/1756-8722-3-7

Accesses  

  • Last 30 days: 186 accesses
  • Last 365 days: 2437 accesses
  • All time: 5587 accesses

Cited by

BioMed Central: 3 citations

Review   Open Access

Ovarian serous carcinoma: recent concepts on its origin and carcinogenesis

Jie Li, Oluwole Fadare, Li Xiang, Beihua Kong, Wenxin Zheng Journal of Hematology & Oncology 2012, 5:8 (9 March 2012)

Review   Open Access Highly Accessed

Current management and novel agents for malignant melanoma

Byung Lee, Nikhil Mukhi, Delong Liu Journal of Hematology & Oncology 2012, 5:3 (14 February 2012)

Research article   Open Access

Myofibrillogenesis regulator 1 (MR-1) is a novel biomarker and potential therapeutic target for human ovarian cancer

Renquan Lu, Min Sun, Jingjing Feng, Xiang Gao, Lin Guo BMC Cancer 2011, 11:270 (25 June 2011)